Saturn Formulations

Mumbai, India Founded: 2017 • Age: 9 yrs
Offers third-party manufacturing and PCD pharma franchise for various drug ranges.
Annual revenue $1.1M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 6 Services tracked
Competitors - Brand Intelligence

About Saturn Formulations

Saturn Formulations is a company based in Mumbai (India) founded in 2017. It operates as a B2B. Saturn Formulations offers products and services including Satlipa Eye Drop, Sat-D3 Nano Shot, Eropam A 1.5, Gisempa-10, and Abivoclin 2.5%.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Saturn Formulations Private Limited
  • Date of Incorporation 04 Oct, 2013
  • Jurisdiction Chandigarh, Chandigarh, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.1 M (USD)
    6.09
    as on Mar 31, 2023
  • Net Profit
    $20.68 K (USD)
    214.01
    as on Mar 31, 2023
  • EBITDA
    $15.27 K (USD)
    -0.78
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Saturn Formulations

Saturn Formulations offers a comprehensive portfolio of products and services, including Satlipa Eye Drop, Sat-D3 Nano Shot, Eropam A 1.5, Gisempa-10, and Abivoclin 2.5%.

Product name locked
Category locked
Primary

Eye drops containing polyethylene glycol for lubrication and eye protection.

Product name locked
Category locked
Locked

Vitamin D3 oral solution to address nutritional deficiencies.

Product name locked
Category locked
Locked

Meropenem avibactam injection for treating bacterial infections.

Product name locked
Category locked
Locked

Empagliflozin tablet for managing diabetes and related conditions.

Product name locked
Category locked
Locked

Clindamycin and benzoyl peroxide gel for skin infection treatment.

Product name locked
Category locked
Locked

Powder with dextrose and vitamins for energy and health support.

Funding Insights of Saturn Formulations

Premium access

Detailed funding history for Saturn Formulations

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Saturn Formulations

Investments
Premium access

Investment portfolio details for Saturn Formulations

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Saturn Formulations

Premium access

Detailed financials for Saturn Formulations

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Saturn Formulations Comparisons

Saturn Formulations Primary company
Description
Offers third-party manufacturing and PCD pharma franchise fo...
Location
Mumbai, India
Founded Year
2017
Annual Revenue
$1.1 M (USD)
Net Profit
$20.68 K (USD)
EBITDA
$15.27 K (USD)
Employees
Not available
Premium access

Peer comparison for Saturn Formulations

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Saturn Formulations

Premium access

Detailed competitors of Saturn Formulations

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Saturn Formulations

Premium access

Complete news archive for Saturn Formulations

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saturn Formulations

Saturn Formulations was founded in 2017.

Saturn Formulations is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Annual revenue of Saturn Formulations is $1.1M as on Mar 31, 2023.

Saturn Formulations is a pharmaceutical company in India specializing in third-party manufacturing and PCD franchise services. They produce a wide range of products including tablets, injectables, and nutraceuticals across categories like gynaecology, dermatology, and orthopedics. Operating from facilities in Panchkula and Mumbai, they ensure high-quality standards with ISO and GMP certifications. Their services cater to healthcare providers and partners through reliable distribution and support.

Saturn Formulations offers Satlipa Eye Drop, Sat-D3 Nano Shot, Eropam A 1.5, Gisempa-10, and 2 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available